# OnKure Therapeutics, Inc.: Form SCHEDULE 13D/A, filed May 30, 2025

- Company: [OnKure Therapeutics, Inc.](/companies/okur.md) (CIK 1637715)
- Form: SCHEDULE 13D/A
- Filed: 2025-05-30
- Accepted by EDGAR: May 30, 2025, 15:57 ET
- Period: not reported
- Accession: 0001636587-25-000030
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1637715/000163658725000030/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1637715/000163658725000030/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1637715/000163658725000030/xslSCHEDULE_13D_X01/primary_doc.xml

Filed May 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001636587-25-000030. Last ingested by Listed: Nov 4, 2026, 17:06 ET. No prices; not investment advice.
